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Dietary Histone Deacetylase Inhibitors in Chemoprevention 
Introduction  
Cancer has remained the second leading cause of death in the United States, with the gap 
between that and the number one cause, heart disease, decreasing significantly over the past 50 
years. As the prevalence of cancer increases throughout the United States, research continues to 
analyze new aspects of its prevention and treatment (Heron & Anderson, 2016). Within the field 
of nutrition, it has become increasingly apparent the importance of preventative medicine 
through dietary components. A recent area of interest within the field of nutrition and epigenetics 
is the use of histone deacetylase (HDAC) inhibitors as chemopreventative agents.  
 
Figure 1. (Heron, Melonie & Anderson, Robert, 2016, Number of deaths due to heart disease and cancer: United 
States, 1950-2014, [Source: NCHS, National Vital Statistics System, Mortality]). 
 
Chemotherapy and Chemoprevention 
 Chemotherapy is the use of medicinal drugs to treat cancer, and is often times used in 
combination with surgery and/or radiation (The American Cancer Society medical and editorial 
content team, 2016). When determining the most effective treatment regimen, doctors take into 
consideration the type and stage of cancer, as well as the patient’s age and overall health. 
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Chemotherapy can be used prior to surgery or radiation to shrink the tumor, while surgery can 
then be used to remove it. Chemotherapy and surgery are frequently followed by radiation, 
which aims to kill any remaining cancer cells (The American Cancer Society medical and 
editorial content team, 2016). However, depending on the size and type of cancer, different 
combinations of these treatments may or may not be used. The importance of chemotherapy in 
treating cancer is its ability to not only kill localized cancer cells, but also cancer cells that have 
metastasized, or spread to another area in the body. Chemotherapy drugs work by targeting the 
cell cycle at different phases in order to terminate, or at least control, cancer cell progression. 
However, chemotherapeutic drugs cannot differentiate between normal, healthy cells and 
cancerous cells. The subsequent damage to normal cells during chemotherapy can lead to 
numerous side effects including changes in behavior, dehydration, eating problems associated 
with changing or damaged taste buds, fatigue, hair loss, nausea, seizures, weight loss, and 
weakness. The accompanying side effects that follow chemotherapy have had researchers 
searching for new treatments that lack such harmful outcomes. (The American Cancer Society 
medical and editorial content team, 2016). Chemoprevention, the focus of this paper, is defined 
in Food as a Source of Anticancerigen Compound, as “the use of dietary agents to prevent the 
development or progression of cancer,” (Hernandez & Chien, 2015). The study of 
chemoprevention is where researchers have begun focusing on compounds and components of 
the diet and their effects.  
Histone Acetylation and Deacetylation   
Within the field of epigenetics and oncology, it has been discovered that histone acetylation and 
deacetylation is an important mechanism for chemoprevention (Ho, Clarke, & Ashwood, 2009). 
Acetylation and deacetylation of nuclear histones is carried out via histone acetyltransferases 
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(HATs) and histone deacetylases (HDACs), respectively. Histone acetyltransferases result in an 
“open” conformation of chromatin, known as euchromatin, while histone deacetylases catalyze 
in a “closed” conformation, known as heterochromatin. The importance of HATs and HDACs in 
cancer prevention and/or suppressed progression is the role that they play in strictly regulating 
the conformation of DNA and the availability of DNA to be acted upon by transcription factors. 
While in the “open” conformation, due to HATs, DNA is exposed to transcription factors, and 
therefore, can undergo transcription. While in the “closed” conformation, due to HDACs, the 
transcription factors do not have access to DNA, and transcription is suppressed. Deacetylation, 
via HDACs, also results in tumor suppressing genes being repressed, or “turned off” 
(Mariadason, 2008). The balance between acetylation and deacetylation via HATs and HDACs 
influences gene expression by allowing or preventing transcription factors, chromatin 
remodeling, and other activation/repression mechanisms. This strictly regulated balance between 
acetylation and deacetylation is important for gene regulation and progression of cell growth.  
Figure 2. (Kim, Bisson, Lohr, Williams, Ho, Dashwood, Rajendran, 2016. Histone and Non-Histone Targets of 
Dietary Deacetylase Inhibitors). 
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Histone Deacetylases 
Histone deacetylases are of particular interest in the development of cancer, as they 
function to close the chromatin conformation of DNA, preventing it from being acted upon by 
transcription factors (Ho, et.al, 2009). While HATs function to add an acetyl group to nuclear 
histones, HDACs work in opposition to remove an acetyl group. Histone deacetylates can also 
mechanistically alter non-histone proteins such as transcription factors, DNA repair mechanisms, 
and tumor various proteins. Each of these non-histone proteins are involved in chromatin 
remodeling, cell cycle regulation, and apoptosis, which all play a role in cancer etiology when 
dysregulated (Mariadason, 2008). 
HDACs are assigned to a specific class (I-IV) depending on their homology to a 
particular component of yeast (Ho, et. al, 2009). The different HDACs of each of the four classes 
have specific functions and regulate various cellular processes. Class I HDACs are ubiquitously 
expressed and are typically located in nucleus. Class II HDACs are tissue-specific, and can be 
found in either the nucleus or cytoplasm. Class III and IV HDACs are not of particular interest in 
this aspect of research, although they do also possess important functions in gene regulation. 
Class I and II histone deacetylases regulate gene expression in multiple ways. The HDACs 
included in both class I and II contain specificity for certain complexes and function to repress 
target gene expression, while other complexes favor other functions within genes, such as 
induced cell cycle arrest or apoptosis (Mariadason, 2008). HDACs function to remove an acetyl 
group from nuclear histones, which leaves the histone positively charged. The now positively 
charged histone then has an increased affinity for negatively charged DNA, which results in the 
repression of transcription, leaving DNA transcriptionally inactive. Another mechanism by 
which HDACs function is the catalysis of transcription factors that possess sequence-specific, 
Commented [SE6]: cite 
Commented [SE7]: cite 
DNA binding properties. Ultimately, the role of acetylation and deacetylation of histones is to 
enhance or repress transcription by increasing or decreasing the binding action of DNA. These 
roles of Class I and II HDAC in normal colon and in colon cancer were reported in a review 
article, HDACs and HDAC inhibitors in colon cancer, by John M. Mariadason (2008). 
Mariadason also states that in normal, noncancerous colons, class I and II HDACs function to 
maintain cell proliferation and survival, while also inhibiting differentiation. 
Class I HDACs have been studied for their role and functions within colon cancer cells as 
well as their role in normal colon cells (Ropero & Esteller, 2007). These HDACs have two 
mechanisms by which they can disrupt gene expression. They may be recruited by specific 
transcription factors to the promotor region of p21, which is a tumor suppressor gene. After 
recruitment, the HDACs can repress transcription of the p21 gene by deacetylation, causing it to 
become transcriptionally inactive. The second mechanism by which Class I HDACs have been 
thought to function is by binding to the transcription factors themselves, causing them to switch 
from transcription activators to transcription repressors. Through each of these mechanisms, 
transcription is repressed via indirect deacetylation or the direct binding of HDACs to 
transcription factors. The role of class II HDACs has not yet been researched in depth, however, 
both class I and II have been shown to suppress the p21 gene via various mechanisms. Class III 
HDACs have been shown to possess properties for regulating energy metabolism, stress 
response, DNA repair mechanisms, apoptosis or deterioration of cells, and deacetylation. Class I, 
II, and III HDACs promote cancer promotion or progression via various mechanisms, which 
leads to the interest in HDAC inhibitors in cancer prevention and treatment (Mariadason, 2008). 
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HDAC Inhibitors 
A specific area of interest within epigenetics and chemoprevention is the role of histone 
deacetylase (HDAC) inhibitors (Ho et.al, 2009). HDAC inhibitors (HDACi) function to prevent 
HDAC from the deacetylation of histones, thereby, restoring DNAs transcriptional activity. 
Histone deacetylation inhibitors (HDACi) have become a prime area of focus for 
chemoprevention, due to their suppression of HDAC functions. HDACi function to suppress or 
limit the dysregulation of genes in cancer and other chronic diseases. Research has shifted 
towards investigating dietary components that may possess these same characteristics and 
function similarly to HDACi, which results in beneficial chemopreventative properties. There are 
two main mechanisms by which dietary components, or isolated phytochemicals, carry out their 
functions similar to HDACi (Bisson et.al, 2011). One mechanism by which isolated 
phytochemicals can have chemotherapeutic properties is by acting as competitive inhibitors by 
binding directly to the catalytic site of HDAC. The second mechanism is the act of allosteric 
inhibitors in which they bind to allosteric sites that are critical for interacting with other proteins. 
Through both of these main mechanisms, isolated phytochemicals as part of the diet are able to 
function similarly to HDAC inhibitors. 
Figure 3. (Bisson, Lohr, Williams, Dashwood, & Rajendran, 2016. Histone and Non-Histone Targets of Dietary 
Deacetylase Inhibitors). 
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Dietary Components  
Various dietary components have been studied for their chemotherapeutic properties due 
to their functional similarity to HDAC inhibitors (Ho et.al, 2009). The similarity in functions of 
HDAC inhibitors and particular dietary components is due to the similarity of their structure, 
which allows them to competitively or allosterically inhibit HDACs. Small chain fatty acids, 
which are the end result of fermentation of dietary fiber, function as HDAC inhibitors by also 
inhibiting cell proliferation, inducing apoptosis in cancer cells, activating tumor suppressor genes 
such as p53, and increasing histone acetylation (Roderick, et. al, 2006). All of these mechanisms 
which small chain fatty acids act are in opposition to the role of HDACs, support HDAC 
inhibition. Another component of the diet that possesses HDAC inhibitor properties is 
isothiocyanates (ITC), which can be consumed via cruciferous vegetables such as broccoli, 
cauliflower, cabbage, kale, and other related vegetables. These foods containing isothiocyanates 
play a role in inhibiting HDACs from performing deacetylation in cancer cells, therefore, 
resulting in increased acetylation. (Dashwood & Ho, 2008). 
Cell-cycle arrest 
 
Many dietary components that function similarly to HDAC inhibitors have been shown to 
induce cell-cycle arrest and apoptosis in damaged, or cancerous, cells (Rajendran et.al, 2011). 
The cell cycle undergoes four stages: G1, S, G2, and M. G1 is the phase in which the cell-cycle 
begins. The S phase is where replication of DNA takes place, as the cell prepares to divide. The 
G2 phase continues to prepare the cell to divide, and, finally, the M phase is where mitosis takes 
place. During this cell cycle, there are checkpoints which serve as regulatory DNA sensors. 
Checkpoints function to check cells for DNA damage, growth factors, nutrients, cell size, and 
other normal cell characteristics (Chen & Kong, 2005). There are checkpoints at each phase of 
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the cell-cycle, and they determine if the cell is permitted to continue to the next phase. When a 
cell becomes damaged, or unfit to move onto the next phase, it will become “arrested” in that 
phase until repair mechanisms fix it or it undergoes apoptosis (Alberts, et al, 2008). The cell 
cycle is of important interest to the dietary components that function similar to HDAC inhibitors 
because many of them induce cell-cycle arrest and apoptosis.  
Figure 4. (Alberts, Johnson, & Lewis, 2002. An Overview of the Cell). 
Specific components of the isothiocyanate group have been studied in order to better 
understand what exactly is producing chemotherapeutic properties in certain foods (Ho et.al, 
2009). Compounds of interest include benzyl-isothiocyanate (BITC), sulforophane (SFN), 
phenethyl-isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHITC), allyl-isothiocyanate 
(AITC), and various other long chain ITCs. Benzyl-isothiocyanate (BITC) has been shown to 
induce cell cycle arrest, activate the tumor suppressor gene p21, and increase acetylation of 
histones (Jeong & Kong, 2005).  Sulforophane (SFN), another dietary component of cruciferous 
vegetables, exhibits important chemotherapeutic properties such as induced DNA damage in 
cancer cells, reduced HDAC activity, increased acetylation of histones, and inhibition of tumor 
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growth. Phenethyl-isothiocyanate (PEITC) functions to demethylate promoter regions and alter 
chromatin states, which both lead to dysregulation of gene expression and eventual death of 
cancer cells. Phenylhexyl isothiocyanate (PHITC) is a compound capable of affecting the 
promoter region of chromatin in cancer cells. Allyl-isothiocyanates (AITC) function in 
chemoprevention via mechanisms that induce apoptosis and cell-cycle arrest in certain cancer 
cells.  Although each of these compounds in isothiocyanates work synergistically to inhibit 
HDAC activity, their mechanisms for doing so vary. (Royston & Tollefsbol, 2015). 
BITC 
One component of isothiocyanates is benzyl-isothiocyanate (BITC), which possesses 
chemotherapeutic characteristics and preventative mechanisms. BITC has been shown to cause 
an upregulation of G2/M phase cell-cycle arrest and eventual apoptosis of the cell (Duval, et. al, 
2016). The two fates of cells that undergo G2/M phase arrest are cell death or severe DNA 
damage that will eventually lead to apoptosis. Not only does BITC function to arrest cell-cycle in 
the G2/M phase, it also modulates the regulatory proteins for that phase as well. In a laboratory-
based study with rats, it was shown that BITC exposure in smaller doses led to a decrease in cell 
growth due to the increase in cell-cycle arrest when compared to the control group (Singh, 2012). 
Larger doses, however, showed decreased cell growth as well as increased apoptosis, therefore, 
leading to an overall larger decrease in cancer cells when compared to the control group. This 
shows the irreversible effects of BITC on both cell-cycle arrest as well as apoptosis induction. In 
addition to BITC’s ability to induce apoptosis and cell-cycle arrest in certain cancer cells, it has 
also shown to induct tumor suppressor gene, p21. This action extends the impact made on the 
prevention of cancer promotion and progression through benzyl-isothiocyanates found in 
cruciferous vegetables (Chen & Kong, 2005).  
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Figure 5. (Lau, Chen, & Wong, 2010. Allyl isothiocyanate induces G2/M arrest in human colorectal 
adenocarcinoma). 
 
PEITC and SFN 
Isothiocyanate compounds of particular interest in the review article, Molecular Targets 
of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention, are 
sulforophane (SFN) and phenethyl-isothiocyanate (PEITC) (Kim et.al, 2016).  Both of these 
compounds interact with the Nuclear Factor Kappa Beta (NFkB) inflammatory pathway. The 
NFkB inflammatory pathway causes an increase in pro-inflammatory cytokines, anti-apoptotic 
genes, and other factors that contribute to an increased risk of chronic disease development. 
PEITC plays a role in inhibiting the inflammatory response of the NFkB pathway by stabilizing 
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha, or IkBalpha, 
which sequesters NFkB in the nucleus, preventing it from initiating the inflammation cascade. 
PEITC and SFN also have similar mechanisms by which they both inhibit the phosphorylation of 
IkBalpha. Inhibition of inflammatory responses plays an important role in the prevention of 
cancer progression due to the role inflammation plays as a risk factor for developing cancer. SFN 
decreases the binding affinity for NFkB via two main mechanisms: direct and indirect binding 
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(Cheung & Kong, 2009). The direct binding of SFN to NFkB happens via the thiol group, which 
leads to the decrease in binding ability of NFkB. The indirect mechanism takes place via redox 
regulators of NFkB. Both of these mechanisms lead to NFkB’s decreased ability to bind, and, 
therefore, inhibits the inflammatory response (Cheung & Kong, 2010).  
Figure 5. (Myzak, M., Ho, E., & Dashwood, R. 2006. Dietary agents as HDACi). 
PEITC and SFN play important roles in the decrease in cancer progression via common 
mechanisms including induced apoptosis and cell-cycle arrest (Cheung et. al, 2009). Apoptosis 
has been predicted to be induced by SFN through reactive oxygen species (ROS). ROS begin the 
apoptotic response by causing dysregulation of the mitochondria, which causes the release of 
cytochrome c, which then causes programmed cell death or apoptosis. PEITC has been shown to 
bind to tubulin within cells which then causes apoptosis with a higher potency than SFN. Cell 
cycle arrest, another common mechanism by which compounds prevent cancer progression, can 
be induced by PEITC and SFN via similar mechanisms. Exposure to each of these compounds 
for three, six, and twelve hours was recorded in vivo (Cheung et. al, 2009). Three hours of 
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exposure to PEITC resulted in a significant decrease in growth of all types of cancer cells. Six 
and twelve-hour exposure to SFN resulted in time-dependent cell-cycle arrest and irreversible 
apoptosis. The six-hour exposure to SFN showed reversible mechanisms, however, the twelve-
hour exposure had more long-lasting effects of cell-cycle arrest and apoptosis. These two 
isothiocyanate compounds have significant impact on the progression of cancer cells via various 
mechanisms and provide promising evidence for future prevention of cancer through dietary 
components (Chen & Kong, 2005). 
Figure 7. (Myzak, Ho, & Dashwood, 2006. Dietary agents as histone deacetylase inhibitors).  
AITC 
 Allyl-isothiocyanate (AITC), another compound in isothiocyanates consumed through 
cruciferous vegetables, also possesses qualities of chemoprevention (Lau, Chen, & Wong, 2010). 
AITC has been shown to induce apoptosis in liver cancer cells, as well as, increase cell-cycle 
arrest and the production of reactive oxygen species (ROS), which can eventually lead to 
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apoptosis as well. Although AITC, and other compounds of isothiocyanates, function in 
chemoprevention, each component does so via various mechanisms. AITC, specifically, 
functions to induce cell-cycle arrest by treating liver cancer cells in mice with 2 to 5 microliters 
for a 72-hour time period. Conclusions of the study include inhibited cell proliferation and 
increased apoptosis of cells. AITC also increased the production of reactive oxygen species via 
oxidative damage, which then led to an increase in the death of liver cancer cells. Each 
mechanism of isothiocyanates, whether it be apoptosis, cell-cycle arrest, increased ROS 
production, or any other action that induces cell death or inhibits cell growth, has an important 
role in chemoprevention. This can all be accomplished through eating cruciferous vegetables, 
which continues to prove the importance of nutrition in the prevention of chronic diseases. 
(Duval, et. al, 2016). 
Cyanohydroxybutene and Glutathione 
 An area of heavy focus within chemoprevention is the role of glutathione (GSH), a 
naturally occurring protein in many cells (Circu & Aw, 2011). GSH has been studied for 
chemopreventive properties and its relationship with dietary components such as 
cyanohydroxybutene (CHB), which is found in cruciferous vegetables. CHB has been studied for 
its ability to activate GSH production in the body. Glutathione plays important roles in 
maintaining the integrity of cells within the body, with its functions including: anti-oxidative 
mechanisms, modulation of immune responses, and cell detoxification and pro-oxidation. 
According to Balendiran, Dabur, and Fraser, each of these anti-cancer properties of GSH play a 
role in cancer prevention (Balendiran, Dabur, & Fraser, 2004). However, elevated levels of GSH 
can actually prevent chemotherapeutic drugs from treating cancer. Therefore, glutathione has 
been shown to be essential in cells in order to maintain proper function, but should not reach 
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elevated levels if an individual has already developed cancer. The important question remains: 
What is the appropriate amount, where the balance between helpful and harmful is most 
beneficial? Researchers have attempted in vivo experiments that reverse the effects of elevated 
levels of GSH in order to restore sensitivity to chemotherapy drugs. Two examples of this in 
Glutathione and Cancer are OTZ and BSO (Balendiran, et. al, 2004). OTZ, oxothiazolidine-4-
carboxylate, monitors levels of GSH within cells, while BSO, buthionine sulfoximine, functions 
to prevent further GSH synthesis. These experiments were carried out by altering GSH levels via 
administering certain amounts of OTZ and BSO, followed by administration of certain 
chemotherapy drugs. The response to the chemo drugs, as well as the levels of GSH, was then 
analyzed and compared. OTZ treatment resulted in lower levels of GSH and an increased 
sensitivity to chemotherapy drugs. BSO resulted in an increased sensitivity to some 
chemotherapy drugs, but a decrease to others. An increase in toxicity of the cell was also 
reported in cells treated with BSO, most likely due to the increased levels of GSH. Glutathione 
carries out many important functions in the body, however, the research that has been conducted 
on GSH and its role in cancer is one of complexity. Elevated levels of GSH have been shown to 
increase protection of cancer cells through decreased sensitivity to chemotherapy drugs, which 
therefore promotes cancer progression. However, with the usage of compounds, such as the 
previously mentioned BSO, in combination with GSH, there is promising hope for future cancer 
prevention and treatment. (Balendiran, Dabur, & Fraser, 2004). 
Diallyl disulfide 
Diallyl disulfide, a main compound found in garlic, is another dietary component that has 
chemopreventative and chemotherapeutic actions through various mechanisms similar to HDAC 
inhibitors (Ling Hui, Li-Feng Lu, Jie He, Guo-Hua Xiao, and Hao Jiang).  Diallyl disulfide 
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(DADS) has multiple targets for the prevention of cancer including apoptosis and cell-cycle 
arrest, inhibition of proliferation, migration, and invasion of cancer cells, and inhibited growth of 
cells both in vivo and in vitro. Induction of apoptosis occurs in the G2/M phase, but in low doses 
can also induce cell cycle arrest in the G0/G1 phase also (Ling, et. al, 2017). Another major 
mechanism that is studied in DADS ability to prevent cancer is the expression of checkpoint 
kinase 1 (ChK1). The important of ChK1 in the initiation of cancer is its ability to detect 
damages and mistakes within the DNA. These checkpoints function to find mistakes and respond 
by making sure that the damaged cell does not continue through the cell-cycle phases. ChK1 
serves important functions in the suppression of cell growth and induction of apoptosis in cancer 
cells. ChK2, however, has not been shown to have the same beneficial outcomes as ChK1. 
DADS activate ChK1, and the overexpression has been shown to cause G2/M cell-cycle arrest 
through the phosphorylation of ChK1. ChK1, as a DNA repair mechanism monitor, helps 
maintain genomic integrity by either holding cell in its current phase until it can be repaired, or 
inducing apoptosis in the damaged cells. For a cell to transition from the G2 phase to mitosis, 
ChK1 must be deactivated. Therefore, an increase in ChK1 in mice showed an increase in G2/M 
phase cells. This shows that ChK1 is necessary for DADS induced cell-cycle arrest (Ling, et. al, 
2014).  
Diallyl trisulfide  
Diallyl trisulfide is another component of garlic that functions similar to diallyl disulfide 
(Jiang, Zhu, Liu, Xu, Zhan, Li, Li, Cai, & Cao, 2016). Cancer prevention through consumption 
of garlic is due largely to diallyl trisulfides (DATS) and diallyl disulfides (DADS), which are 
important preventative and therapeutic components. DATS express these properties via various 
mechanisms that lead to increased reactive oxygen species (ROS) production, decreased blood 
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pressure and cholesterol, or increased aggregation of platelets. The overall effect of DATS on 
cancer cells is primarily apoptosis and decreased cell proliferation. DATS, not only protect 
against cancer promotion and progression, but also guards against cardiovascular diseases via 
anti-inflammatory and antioxidant properties. Whenever DATS are metabolized in the body, by 
glutathione, they then form hydrogen sulfide, which has anti-inflammatory and antioxidant 
properties. These properties of DATS are important in chemoprevention and prevention of other 
chronic diseases (Jiang, et. al, 2017). 
Allyl Mercaptan 
 Allyl mercaptan (AM) is an organosulfur compound found in garlic that functions as a 
dietary histone deacetylase inhibitor (HDACi) (Oi, Kawada, Shishido, Wada, Kominato, 
Nishimura, Ariga, & Iwai, 1998). Among the organosulfur compounds in the diet, AM has been 
shown to be of the most potent in the role of cancer prevention. AM has been studied in vivo for 
its chemopreventative effects, with experiments focusing on cell cycle arrest and apoptosis of 
cancer cells. AM experiments showed that it possesses anti-proliferative and hyperacetylation of 
cancer cells. Hyperacetylation of cells via AM has been linked to activation of p21, a tumor 
suppressor gene, which is repressed by HDACs. By activating p21, there was a reported 
subsequent increase in binding of p53, another tumor suppressor gene. Both p21 and p53 
function synergistically to suppress cancer and tumor growth. Another mechanism by which AM 
prevents cancer cells is by acting as a competitive inhibitor of HDAC. These functions of AM 
have been shown to result in cell-cycle arrest and eventual apoptosis of cancer cells. Whenever 
AM was administered at ~20 micro molar, there was a resulting 50% decrease in HDAC activity, 
which supports the hypothesis that AM acts similarly to HDAC inhibitors (Nian, Delage, Pinto, 
& Dashwood, 2008). 
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Limitations 
Nutrition has been and always will be of the utmost importance in maintaining a healthy 
lifestyle, and has also been proved to aid in the prevention of chronic diseases such as 
cardiovascular disease, type II diabetes, cancer, and other inflammatory diseases. (Hernandez & 
Chien, 2015). Cruciferous vegetables and garlic are shown to be inversely related to the risk of 
certain cancers, such as breast, lung, colorectal, and prostate. However, an area of research, 
which appears to still be in its infancy, is the amount of consumption necessary for each of these 
previously mentioned dietary factors to provide these beneficial chemopreventative properties. A 
common question includes: “How much would I need to eat in order to benefit from the positive 
effects these foods offer,” and this is a valid inquiry. As researchers attempt to understand the 
amount of isothiocyanates people with or without cancer have been exposed to, there are many 
factors to consider which make that difficult (Hernandez & Chien, 2015). The bioavailability and 
chemical digestion/metabolism processes of cruciferous vegetables, for example, are areas of 
interest in the field of nutrition and chemoprevention. Some research studies have focused on 
measuring the amount of isothiocyanates excreted via urine, but it still remains difficult to 
understand exactly how much is actually put to use in the body through cruciferous vegetable 
intake. While many organizations have recommended dietary intakes for vegetables, there are 
few recommendations solely focused on cruciferous vegetables. According to Higdon et. al, 
individuals should aim for at least 5 servings of cruciferous vegetables per week.  
Conclusion 
 Chemotherapy is a common and, for most cases, successful treatment for cancer (The 
American Cancer Society medical and editorial content team, 2016). However, accompanying 
this treatment, both during and after, are harmful side effects. Researchers continue to search for 
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new treatments, and hopeful cures, for this chronic disease which affects millions each year. 
Exploring every aspect of potential treatment, many research studies have focused on the effects 
of various foods and their beneficial properties and potential roles in chemoprevention of certain 
tumors. Through such research, chemopreventative properties have been attributed to 
phytochemicals in various fruits, vegetables, and other plants. Of specific interest in this paper 
are garlic and cruciferous vegetables, such as broccoli, cabbage, cauliflower, and brussel sprouts. 
Such epigenetic research includes the study of histone acetylation (HATs), histone deacetylation 
(HDACs), and histone deacetylase inhibitors (HDACi). The role of each of these is to either 
activate or deactivate the transcription of DNA via histone acetylation, deacetylation, or the 
inhibition of deacetylation. The tightly kept balance between the acetylation and deacetylation of 
histones has been examined and analyzed for the role in preventative properties against cancer 
cell progression (Kim et. al, 2016). Potential beneficial roles of chemoprevention have been 
attributed to HDAC inhibitors, and the similarity of these dietary components to HDAC 
inhibitors has been a subject of heavy focus within epigenetic research. The role of HDAC 
inhibitors has provided promising hope for the future of chemoprevention, and provided insight 
into dietary components and their beneficial effects. Via numerous mechanisms, many of these 
dietary components have in common the ability to induce cell-cycle arrest and apoptosis in 
cancer cells. In addition to cell-cycle arrest and apoptosis of cancer cells, these components of 
cruciferous vegetables and garlic have numerous other beneficial properties including anti-
inflammation, decreased tumor invasion, and anti-viral and anti-bacterial effects (Hernandez & 
Chien, 2016). The mechanisms by which these components of cruciferous vegetables and garlic 
act have been shown to positively impact chemoprevention, and provide promising information 
for the future of cancer prevention and potential treatments.  
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